English
Zoom-Zoom+Black contrastBlue contrastWhite contrast

How to use the speech recognition tool?

NCT01490827

Argus II retinal prosthesis system post-market surveillance study protocol (Argus II PM-01-01)

Argus II retinal prosthesis system post-market surveillance study protocol (Argus II PM-01-01).

Type: Interventional



Status of the trial: Completed

Orphan Drug Recognition: No

Inclusion

  • Opening Date: 2011-11-01
  • Closing Date: 2021-05-01

Criteria

Inclusion: Adults, age 25 or older, with severe to profound outer retinal degeneration (not including Age-related Macular Degeneration)

More information

Children: No

Adults: Yes

Funder Type: governmental organisation

HCP: Other investigators


Within ERN-EYE members

Principal investigators




Other investigators

Workgroups

  • Retinal Rare Eye Diseases (WG1)

Subscribe to our mailing list

* indicates required

This ERN is supported by: